Filtered By:
Education: Academia

This page shows you your search results in order of date. This is page number 13.

Order by Relevance | Date

Total 283 results found since Jan 2013.

Gawande, Frankl, and Why “Less Is More” Is More of the Same
By MICHEL ACCAD, MD My last post was prompted by a reader’s comment where Victor Frankl’s Man’s Search for Meaning and Atul Gawande’s Being Mortal were juxtaposed.  Since receiving that message, I have had occasion to notice that others also associate these two books. For example, both are mentioned positively in this moving article by Dr. Clare Luz about a friend’s suicide, and in these tweets from Dr. Paddy Barrett’s podcast program: Friends and patients of mine have likewise mentioned these two works to me, expressing praise and testifying to the deep impact the books have had on them. I suspect ...
Source: The Health Care Blog - February 3, 2016 Category: Consumer Health News Authors: Simon Nath Tags: THCB MICHEL ACCAD Source Type: blogs

Short-selling Private Practice
By KAREN SIBERT, MD Today is a remarkable day for me. I’m officially leaving private practice after almost 18 years, to return to academic medicine with a faculty position in a highly regarded California department of anesthesiology. Why would I do that? There are many positive reasons. I believe in the teaching mission of academic medicine:  to train the anesthesiologists of the future, and the scientists who will advance medical care. I enjoy teaching. The years I’ve spent at the head of the operating room table, anesthetizing patients every day, have given me a great deal of hands-on experience (and at least some ...
Source: The Health Care Blog - February 3, 2016 Category: Consumer Health News Authors: Simon Nath Tags: THCB Karen Sibert Source Type: blogs

Data Parasites?
By DAVID SHAYWITZ, MD In just four years, it seems, data science has devolved from the “sexiest job of the 21stcentury” to a community of “research parasites.” The latest assessment is courtesy of an editorial in the New England Journal of Medicine (NEJM), written by editor-in-chief Jeff Drazen, along with Dan Longo. Essentially, Longo and Drazen argue that while the Platonic ideal of rich data sharing is lovely, reality is not so pretty. First, Longo and Drazen allege, researchers who weren’t involved in gathering the original data often lack essential appreciation for how it was gathered, and thus may misinterp...
Source: The Health Care Blog - January 23, 2016 Category: Consumer Health News Authors: Simon Nath Tags: THCB David Shaywitz Source Type: blogs

One Year, Two Roles: A Perspective From a New Faculty Cardiologist and New Mom
This article was authored by Monika Sanghavi, MD, assistant professor in the division of cardiology at the University of Texas Southwestern Medical Center in Dallas, TX, and a member of the ACC Women in Cardiology Section. This academic year was … Continue reading → The post One Year, Two Roles: A Perspective From a New Faculty Cardiologist and New Mom appeared first on ACC in Touch Blog.
Source: ACC in Touch Blog - December 9, 2015 Category: Cardiology Authors: Admin Tags: Membership guest post Leadership/Professionalism women Source Type: blogs

This Is Not A Disruptive Blog Post
By MICHEL ACCAD, MD Frank Knight, risk and uncertainty In this article, I wish to introduce the reader to the theory of entrepreneurship advanced by Frank Knight (1885-1972), and show that the common, everyday work of the physician could be considered a form of entrepreneurial activity in the Knightian sense. Knight was an influential American economist. He is best known for his book Risk, Uncertainty, and Profit in which he proposed to distinguish risk and uncertainty as follows: Risk pertains to situations where outcomes occur with a frequency that is quantifiable according to probability distributions. Risk may b...
Source: The Health Care Blog - December 8, 2015 Category: Consumer Health News Authors: Simon Nath Tags: THCB MICHEL ACCAD Source Type: blogs

FDA Agency Update December 2015
As 2015 comes to a close for the FDA, it remains an agency in transition. The agency should soon see a new commissioner and may be the subject of legislative overhauls. We have recently reported on the FDA's new patient engagement advisory committee, anticipated biosimilars naming guidance, PDUFA reauthorization, and continued issuance of warning letters. FDA funding, drug approvals: key concerns RAPS reported FDA Acting Commissioner Ostroff's recent comments, describing the importance of biomarkers in drug development, inspection policies, and patient-centric approaches. With so much talk of FDA reform, his comments on ...
Source: Policy and Medicine - December 3, 2015 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

Research and Reviews in the Fastlane 110
Welcome to the 110th edition of Research and Reviews in the Fastlane. R&R in the Fastlane is a free resource that harnesses the power of social media to allow some of the best and brightest emergency medicine and critical care clinicians from all over the world tell us what they think is worth reading from the published literature. This edition contains 6 recommended reads. The R&R Editorial Team includes Jeremy Fried, Nudrat Rashid, Soren Rudolph, Anand Swaminathan and, of course, Chris Nickson. Find more R&R in the Fastlane reviews in the R&R Archive, read more about the R&R project or check ou...
Source: Life in the Fast Lane - November 25, 2015 Category: Emergency Medicine Authors: Anand Swaminathan Tags: Emergency Medicine Haematology Infectious Disease Intensive Care LITFL review Pediatrics Resuscitation Toxicology and Toxinology critical care Education literature R&R in the FASTLANE recommendations Research and Review Source Type: blogs

How to Safeguard your Career in Treacherous Healthcare Times
By MICHEL ACCAD, MD Dear medical student, I am honored by the opportunity to offer some advice on how to safeguard your professional career in a treacherous healthcare system. I will not elaborate on why I think the healthcare system is “treacherous.”  I will assume—and even hope—that you have at least some inkling that things are not so rosy in the world of medicine. I am also not going to give any actual advice.  I’m a fan of Socrates, so I believe that it is more constructive to challenge you with pointed questions.  The real advice will come to you naturally as you proceed to answer these questions for you...
Source: The Health Care Blog - November 25, 2015 Category: Consumer Health News Authors: Simon Nath Tags: THCB MICHEL ACCAD Source Type: blogs

Nominee for New FDA Commissioner Derived Salary from Six Pharmaceutical Companies LAST YEAR
In President Obama's first inauguration speech, he promised to restore science to its proper place in government by shielding the regulatory process from corporate influence. One of his specific proposals to carry out this promise was to prevent anyone with a severe corporate conflict of interest from serving in the executive branch until at least one full year had gone by without the conflict in place. Thus, if you received salary from a pharmaceutical company in 2014, you would not be permitted to serve as the FDA Commissioner at least until 2016.Unfortunately, as we have repeatedly seen campaign promises wither, this on...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - November 19, 2015 Category: Addiction Source Type: blogs

Research & Reviews in the Fastlane 109
This article synthesizes data from 58 publications to help guide clinicians in evaluating patients with chest pain for ACS. Overall, individual pieces of the history and physical don’t have the best test characteristics. Prior abnormal stress test (LR 3.1), peripheral arterial disease (LR 2.7) and pain radiating to both arms (LR 2.6) have the best, albeit weak, test characteristics. EKG findings were marginally better after exclusion of the obvious STEMI (ST segment depression LR 5.3, any ischemia LR 3.6). On the other hand, the HEART score performed quite well. For high-risk range HEART score (7-10) the + LR = 13 an...
Source: Life in the Fast Lane - November 19, 2015 Category: Emergency Medicine Authors: Jeremy Fried Tags: Airway Cardiology Education Emergency Medicine Intensive Care R&R in the FASTLANE Resuscitation Trauma critical care EBM literature recommendations research and reviews Source Type: blogs

5 ways radiologists can reduce unnecessary tests
The Lown Institute advocates rational use of medical resources. This is a noble goal and worthy of the attention of radiologists. It was recently RightCare Action Week: Here are five simple things any radiologist can do that week, and the following weeks. This will improve patient care by avoiding unnecessary tests. 1. Speak to the referring clinician, at least sometimes, if not often, perhaps twice a day. The conversation need not be adversarial. Ask before the imaging two simple questions. What will you do if the test is positive? What will you do if the test is negative? Inquire four weeks after the imaging is done i...
Source: Kevin, M.D. - Medical Weblog - November 3, 2015 Category: Journals (General) Authors: Tags: Physician Radiology Source Type: blogs

Right Care Action Week – What can Radiologists do?
By SAURABH JHA, MD The Lown Institute advocates rational use of medical resources. This is a noble goal and worthy of the attention of radiologists. This week is the right care action week. Here are five simple things any radiologist can do this week, and the following weeks. This will improve patient care by avoiding unnecessary tests. Speak to the referring clinician, at least sometimes, if not often, perhaps twice a day. The conversation need not be adversarial. Ask before the imaging two simple questions. What will you do if the test is positive? What will you do if the test is negative? Inquire four weeks after the im...
Source: The Health Care Blog - October 20, 2015 Category: Consumer Health News Authors: Simon Nath Tags: THCB Saurabh Jha Source Type: blogs

If CTO is safe , should we allow all PCI ineligible ATO to evolve as CTO ?
Hot debate in STEMI Acute total obstruction (ATO) of coronary artery is an emergency .Opening it  by pharmacological or catheter is the  standard ( logical ) protocol.However, time plays a crucial role in this coronary re-perfusion game.It can either be a sure shot of success or end up in total spoilsport. One more issue as important as time is from the overflowing scientific data  fired  by different regulators  in conflicting directions  (Also called knowledge) . What to do with STEMI coming late ? ATO with cardiogenic shock is an  absolute emergency at any time. Symptomatic ATO  other than CS beyond 24 hrs stil...
Source: Dr.S.Venkatesan MD - October 20, 2015 Category: Cardiology Authors: dr s venkatesan Tags: acute coroanry syndrome cto chronic total occlusion open artery hypothesis ato vs cto management stemi Source Type: blogs

An F.D.A. Commissioner With Ties to the Pharmaceutical Industry? Heaven Forbid?
<p style="font-size: 11.2px; line-height: 19.04px;"><span style="font-size: 11.2px; line-height: 19.04px;">On September 16, 2015, </span><a style="font-size: 11.2px; line-height: 19.04px;" href="http://www.nytimes.com/2015/09/16/health/cardiologist-nominated-to-be-head-of-fda.html">President Obama nominated</a><span style="font-size: 11.2px; line-height: 19.04px;"> the internationally known Duke University cardiologist-researcher </span><a style="font-size: 11.2px; line-height: 19.04px;" href="https://medicine...
Source: blog.bioethics.net - October 12, 2015 Category: Medical Ethics Authors: Hayley Dittus-Doria Tags: Conflict of Interest Health Care drug safety FDA Research and Development syndicated Source Type: blogs

Study Looks At How Many Industry Boards of Directors Have Academic Affiliations
Conflict of interest rules for the medical community have been in the spotlight lately, though they typically center around rules that prohibit or restrict physicians from enjoying lunch on behalf of a pharmaceutical company or stocking their office with pens. A new study conducted by researchers from the University of Pittsburgh School of Medicine and published in the British Medical Journal recently decided to look at conflicts of interest from a different perspective: they looked at how many for-profit healthcare company positions were occupied by people with academic affiliations. These researchers analyzed public disc...
Source: Policy and Medicine - October 7, 2015 Category: American Health Authors: Policy and Medicine Writing Staff Source Type: blogs